Get started
El-Nile Co. for Pharmaceuticals & Chemical IndustriesEl-Nile Co. for Pharmaceuticals & Chemical IndustriesEl-Nile Co. for Pharmaceuticals & Chemical Industries

El-Nile Co. for Pharmaceuticals & Chemical Industries

No trades
No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with El-Nile Co. for Pharmaceuticals & Chemical Industries



Key stats


Market capitalization
‪19.90 B‬ EGP
Dividend yield (indicated)
0.50%
Price to earnings Ratio (TTM)
73.89
Basic EPS (TTM)
6.23 EGP
Net income (FY)
‪125.73 M‬ EGP
Revenue (FY)
‪1.29 B‬ EGP
Shares float
‪14.17 M‬
Beta (1Y)
0.19

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Khalid Salahuddin Mahmoud Haggage
Website
nilepharma.com.eg
Headquarters
Cairo
Founded
1962
IPO date
May 14, 1995
ISIN
EGS38331C012
FIGI
BBG000H1GY88
Identifiers
ISIN EGS38331C012
El-Nile Co. for Pharmaceuticals & Chemical Industries engages in the manufacture and sale of pharmaceuticals, chemicals, cosmetics, and medical supplies.Its products include analgesic, anti-inflammatory, anesthetic, anti-diabetics, and antiseptic medicines; skin preparations and hair tonics; and vitamins and minerals.The company was founded in 1962 and is headquartered in Cairo, Egypt.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of NIPH is 410.02 EGP — it has decreased by −7.29% in the past 24 hours. Watch El-Nile Co. for Pharmaceuticals & Chemical Industries stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange El-Nile Co. for Pharmaceuticals & Chemical Industries stocks are traded under the ticker NIPH.
NIPH stock has risen by 36.16% compared to the previous week, the month change is a 109.41% rise, over the last year El-Nile Co. for Pharmaceuticals & Chemical Industries has showed a 789.41% increase.
NIPH reached its all-time high on Aug 11, 2026 with the price of 516.96 EGP, and its all-time low was 2.04 EGP and was reached on Jan 17, 2016. View more price dynamics on NIPH chart.
See other stocks reaching their highest and lowest prices.
NIPH stock is 23.60% volatile and has beta coefficient of 0.19. Track El-Nile Co. for Pharmaceuticals & Chemical Industries stock price on the chart and check out the list of the most volatile stocks — is El-Nile Co. for Pharmaceuticals & Chemical Industries there?
Today El-Nile Co. for Pharmaceuticals & Chemical Industries has the market capitalization of ‪19.90 B‬, it has decreased by −3.82% over the last week.
Yes, you can track El-Nile Co. for Pharmaceuticals & Chemical Industries financials in yearly and quarterly reports right on TradingView.
NIPH net income for the last quarter is ‪68.99 M‬ EGP, while the quarter before that showed ‪63.55 M‬ EGP of net income which accounts for 0.00% change. Track more El-Nile Co. for Pharmaceuticals & Chemical Industries financial stats to get the full picture.
Yes, NIPH dividends are paid annually. The last dividend per share was 2.00 EGP. As of today, Dividend Yield (TTM)% is 0.50%. Tracking El-Nile Co. for Pharmaceuticals & Chemical Industries dividends might help you take more informed decisions.
El-Nile Co. for Pharmaceuticals & Chemical Industries dividend yield was 6.15% in 2025, and payout ratio reached 71.69%. The year before the numbers were 13.50% and 104.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. El-Nile Co. for Pharmaceuticals & Chemical Industries EBITDA is ‪677.03 M‬ EGP, and current EBITDA margin is 29.02%. See more stats in El-Nile Co. for Pharmaceuticals & Chemical Industries financial statements.
Like other stocks, NIPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade El-Nile Co. for Pharmaceuticals & Chemical Industries stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So El-Nile Co. for Pharmaceuticals & Chemical Industries technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating El-Nile Co. for Pharmaceuticals & Chemical Industries stock shows the strong buy signal. See more of El-Nile Co. for Pharmaceuticals & Chemical Industries technicals for a more comprehensive analysis.